✦ LIBER ✦

Task force II: Recommendations for subjects with ischemic heart disease

✍ Scribed by Likoff; Knoebel; Amsterdam; Frykholm; McMeekin; Morris; Roberts

Book ID: 115666043
Publisher: Elsevier Science
Year: 1975
Tongue: English
Weight: 228 KB
Volume: 36
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(75)90158-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Task force III: Recommendations for post

Task force III: Recommendations for postoperative patients with ischemic heart disease

✍ Rackley; Collins; Gordon; Mason; Reis; Urschel; Williams 📂 Article 📅 1975 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Coverage of recommended vaccinations in

Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men

✍ Thomas Ernst Dorner; Éva Ràsky; Katharina Viktoria Stein; Willibald Julius Stron 📂 Article 📅 2011 🏛 Springer Vienna 🌐 German ⚖ 107 KB

Guidelines for the Management of Patient

Guidelines for the Management of Patients With Valvular Heart Disease : Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease)

✍ Bonow, R. O.; Carabello, B.; de Leon, A. C.; Edmunds, L. H.; Fedderly, B. J.; Fr 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 575 KB

ACC/AHA guidelines for the management of

ACC/AHA guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on management of patients with valvular heart disease)

✍ RobertO. Bonow; Blase Carabello; AntonioC. de Leon Jr.; L.Henry Edmunds Jr.; Bra 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 701 KB

ACCF/AHA/AMA–PCPI 2011 Performance Measu

ACCF/AHA/AMA–PCPI 2011 Performance Measures for Adults With Coronary Artery Disease and Hypertension: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association–Physician Consortium for Performance Improvement

✍ Joseph Drozda Jr.; Joseph V. Messer; John Spertus; Bruce Abramowitz; Karen Alexa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 640 KB

ABSORB II randomized controlled trial: A

ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB